METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS
Clinical trials for METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS explained in plain language.
Never miss a new study
Get alerted when new METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS trials appear
Sign up with your email to follow new studies for METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to halt scarring in advanced fatty liver disease
Disease control OngoingThis study is testing whether an investigational drug called efinopegdutide can help treat a serious form of fatty liver disease called MASH that has progressed to cause permanent scarring (cirrhosis). About 80 adults with this condition will receive either the drug or a placebo …
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
Scientists track 500 people to crack the code on weight loss
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to understand what factors help people with obesity succeed at losing weight. Researchers will follow 500 adults from a weight loss clinic, collecting detailed health and lifestyle information. The goal is to use this data to build better, more personalized weight…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC